Dr. W. Gotlieb

12 posts

Dr. W. Gotlieb

Dr. W. Gotlieb

@GotliebW

Professor of Ob-Gyn & Oncology, Chief Department of Ob- Gyn Jewish General Hospital, McGill University, Montreal, Canada

Montreal Katılım Ekim 2019
4 Takip Edilen141 Takipçiler
Dr. W. Gotlieb
Dr. W. Gotlieb@GotliebW·
@leitaomd This just supports that there is room to further improve some of the technical aspects of MIS in order to allow patients to benefit, and not to discard the entire approach
English
0
0
1
0
IJGC
IJGC@IJGConline·
#IJGCclub Poll4 Clinical scenario
IJGC tweet media
Oslo, Norway 🇳🇴 Italiano
1
1
2
0
Dr. W. Gotlieb
Dr. W. Gotlieb@GotliebW·
limitations: major residual disease post chemo that is retracted and difficult to resect and disease in difficult to reach areas, such as smaller curvature, post diaphragm, gastrosplenic lig, multiple bowel sites #ijgcclub, @ESGO_society, @AAGLJMIG, @IGCSsociety, ijgconline
English
0
1
7
0
Dr. W. Gotlieb
Dr. W. Gotlieb@GotliebW·
@IJGConline major residual disease post chemo that is retracted and difficult to resect and disease in difficult to reach areas, such as smaller curvature, post diaphragm, gastrosplenic lig, multiple bowel sites
English
0
2
4
0
IJGC
IJGC@IJGConline·
#IJGCclub Q2 for Dr. Gotlieb @GotliebW In your opinion, what are the limitations of robotic surgery/MIS in cytoreductive surgery?
English
1
1
1
0
Dr. W. Gotlieb
Dr. W. Gotlieb@GotliebW·
@IJGConline @ESGO_society @GynMe4 @me4_so @AAGLJMIG Patients who responded well and are expected to achieve R=0 by robotics. Criteria include disappearance of signs of carcinomatosis and unresectable disease on CT, a drastic decrease in CA125, and a final evaluation by laparoscopy confirming the possibility that R=0 can be reached
English
0
0
1
0
Dr. W. Gotlieb
Dr. W. Gotlieb@GotliebW·
@pedroramirezMD @IJGConline @IGCSociety @ESGO_society Thank you Pedro, a RCT is definitely warranted to confirm cohort data, and with the available data today one can consider offering it to patients in whom complete cytoreduction can be achieved, as long as the patients are well informed and correctly consented
English
0
0
1
0
Dr. W. Gotlieb
Dr. W. Gotlieb@GotliebW·
Expectation that you can obtain complete cytoreduction: such as disappearance of signs of carcinomatosis and unresectable Dz on CT, drastic decrease in CA125, and then evaluation by laparoscopy to make the final decision
T.T.@ttawfeeq

@IJGConline Q: what makes a good criteria to select? #IJGCclub

English
1
3
7
0
Ane Gerda Z Eriksson MD PhD
Ane Gerda Z Eriksson MD PhD@agz_eriksson·
November #IJGCclub Poll2 Would you take part in the #LANCE trial? I would ✅ @JennyMueller_ @RobinsonRossiGO @PamSolimanMD @twigem2a Join our discussion today at 8pm CET @duciej13 @beth_karlan @DrLB @me4_so
IJGC@IJGConline

#IJGCclub Poll2 “Would you be interested to take part in a RCT on laparotomy vs MIS in interval cytoreductive #surgery for #OvarianCancer?” @headofmelon @GynMe4 @RauhHainMD @AngelesFite @GotliebW @AStrojnaMD @annafagottimd @pedroramirezMD #OncoAlert

Oslo, Norway 🇳🇴 English
1
0
3
0